Funko Inc vs Nuwellis Inc — how do they compare? Funko Inc trades at $6.44 (market cap $363.97M), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Funko Inc is far larger — about 165.4× Nuwellis Inc's market cap, and Funko Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Nuwellis Inc for 26 Days on average.
| FNKO | NUWE | |
|---|---|---|
Market Cap | $363.97M | $2.20M |
Volume | 1,422,651 | 121,544 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $146.65 |
52-Week Low | $2.81 | $0.68 |
Typical Hold Time | 33 Days | 26 Days |
Enterprise Value | $584.62M | -$1.52M |
Signals from Pluang's Aura AI — not financial advice
Funko (FNKO) trades at $6.50, up 3.01% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with recent earnings beats and raised EBITDA guidance, though profitability remains challenged with negative net margins. Analyst consensus leans Hold with a $7.58 price target, while institutional sentiment is mixed amid ongoing business transformation efforts.
Investment outlook balances technical strength against fundamental challenges. The stock offers potential upside to analyst targets but faces execution risks in maintaining recent operational improvements. Key catalysts include continued margin expansion and debt reduction, while risks include consumer discretionary spending pressures and competitive market positioning.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →